Genitourinary Cancer
News
Dexamethasone eases end-of-life cancer-related fatigue
Major finding: Scores on the FACIT fatigue subscale improved by an average of 6 points in patients treated with dexamethasone, compared with 3...
News
Androgen deprivation decreases lung tumors in men with prostate cancer
Major finding: Men with prostate cancer who underwent androgen blockade were 17% less likely to develop secondary non–small cell lung cancer than...
Video
Novel therapies extend life in patients with metastatic prostate cancer
News
High selenium exposure may lower incidence of advanced prostate cancer
Major finding: The risk for advanced prostate cancer was more than 60% lower in men with the highest levels of toenail selenium, when compared...
News
ACP: PSA screening's harms outweigh benefits
News
Inconclusive results seen for intermittent androgen deprivation
Major finding: Median survival was 5.1 years with intermittent androgen-deprivation therapy and 5.8 years with continuous androgen-deprivation...
News
Baldness, prostate cancer linked among black men
Major finding: Black men aged 60 years and younger who have frontal baldness had more than double in the risk of both high-stage and high-grade...
News
Gene alteration lowers bladder cancer risk
Major finding: A 0.77-fold reduced risk of bladder cancer was associated with a single nucleotide polymorphism (rs10759) found on the RGS4 gene....
Conference Coverage
MVAC plus cystectomy boosts bladder cancer survival
Major finding: Overall survival was better with MVAC plus radical cystectomy (median, 102 months) than with radical cystectomy alone, (median, 81...
News
Dasatinib adds no survival benefit to docetaxel in mCRPC
Major finding: Overall survival was 21.5 months when dasatinib was added to docetaxel and prednisone and 21.2 months without dasatinib.Data source...
News
Aflibercept adds toxicity and no survival benefit in mCRPC
Major finding: Overall survival of patients in the aflibercept arm was 22.1 months, compared with 21.2 months in the placebo arm (HR = 0.94; P = ....